Paul Evans, Velocity President and CEO, was featured in a Triangle Business Journal article covering Velocity’s recent partnership announcement with Luminis Health.
As Paul notes in the article, hospitals play a crucial role in clinical research due to their patient populations, particularly in specialized fields like oncology. Velocity will take over the operation of the hospital’s existing clinical research capabilities in collaboration with Luminis Health’s world-class physician base. By doing so, Velocity will deliver increased efficiencies while bringing more clinical trials to a broader patient population.
With oncology representing a significant portion of the industry’s development pipeline, this expansion in the U.S. — along with Velocity’s existing oncology capabilities in Poland — will meet a growing client demand for Velocity’s site capabilities in this expansive therapeutic area.
Read the full article: https://www.bizjournals.com/triangle/news/2024/06/17/velocity-clinical-research-luminis-health-deal.html
